Oblina, Ofrix B.
HRN: 26-48-92 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2025
CEFUROXIME 1.5GM (VIAL)
01/09/2025
01/16/2025
IVT
1.5 Gms
Q 8
Pelvic Lap
Waiting Final Action
01/09/2025
CEFUROXIME 500MG (TAB)
01/09/2025
01/15/2025
PO
1tab
BID
CS
Waiting Final Action